CareDx Execs Stack Up Shares Ahead of AlloHeme Validation, Signaling Bold Confidence
CareDx insiders, led by COO Kennedy Keith, are buying RSUs & PRSUs—signaling confidence ahead of AlloHeme validation and a potential upside for the stock.
4 minutes to read

